contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


sensodetect-ab-sensodetect-achieves-ai-breakthrough-unlocking-scalable-market-leadership-in-neuropsychiatric-diagnostics

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

SensoDetect operates in the healthcare sector. The company specializes in developing medical equipment that is used to analyze how a patient's brain reacts to sound stimuli. The technology is used in psychiatry to distinguish potential mental illnesses. The product consists of electrodes that are attached to the patient's head and then analyze brain activity. The results are compared against a database for further analysis. SensoDetect was founded in 2005 and is headquartered in Lund.

SensoDetect

SensoDetect AB (publ) today announced a proprietary technological breakthrough that positions the company to capture a significant share of the global neuropsychiatric diagnostics market. By...

SensoDetect AB (publ) today announced a proprietary technological breakthrough that positions the company to capture a significant share of the global neuropsychiatric diagnostics market. By applying advanced artificial intelligence (AI) to its unique database of Brainstem Evoked Response Audiometry (BERA) tests, SensoDetect has achieved diagnostic accuracy for ADHD that is competitive with complex, costly methods like MRI and EEG, but with superior scalability and speed.This AI-powered analysis validates the company's path to leadership in a market seeking objective, scalable diagnostic tools. Recent studies (Ref 1 and 2) highlight AI's potential to achieve 70-95% diagnostic accuracy in psychiatry, but these rely on expensive, time-consuming methods like MRI and EEG.Commercial advantagesSensoDetect is the first company to successfully apply AI to an Auditory Brainstem Response (ABR) database, creating a decisive competitive moat. The Company's solution matches the accuracy of leading methods while offering critical commercial advantages:<ul>	<li>Speed &amp; Workflow: A complete test in under 10 minutes, versus hours for alternatives.</li>	<li>Cost-Efficiency: Requires no multimillion-dollar capital equipment.</li>	<li>Patient Comfort: Non-intrusive and simple to administer.</li>	<li>Scalability: Easily deployed in clinics worldwide.</li></ul>"This isn't just an innovation; it's a fundamental competitive shift," said P-A Hedin, CEO of SensoDetect. "We are leveraging our vast, proprietary BERA database-an asset no competitor can replicate-to train AI models that deliver gold-standard accuracy with unprecedented practicality. This synergy directly translates into a faster commercial rollout, stronger IP protection, and a clear trajectory for market leadership."Strategic Value and Next StepsThis advancement provides a dual benefit: it immediately enhances the value of SensoDetect's historical data and accelerates the ongoing validation of its core BERA technology. The company will now focus on integrating this AI software into its global commercial strategy, which is expected to significantly accelerate adoption rates and create new, high-value revenue streams through IP licensing.References1&nbsp;Zaheer, A., &amp; Akhtar, A. (2025). Artificial intelligence as a support to diagnose ADHD: An insight of unorthodox approaches: A scoping review. Child Neuropsychology.2&nbsp;Deepika, M., Sharma, S., &amp; Arora, S. (2025). Redefining parameter-efficiency in ADHD diagnosis: A lightweight attention-driven Kolmogorov-Arnold network with reduced parameter complexity and a novel activation function. Psychiatry Research: Neuroimaging, 351, 112016.<div></div>

SensoDetect AB: SensoDetect achieves AI breakthrough, unlocking scalable market leadership in neuropsychiatric diagnostics